0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Crohn Disease Drug"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Crohn's Disease (CD) Treatment Market Report 2025 - Product Thumbnail Image

Crohn's Disease (CD) Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Crohn's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 240 Pages
  • Global
From
EUR$3,000USDGBP
Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 1389 Pages
  • Global
From
EUR$3,450USDGBP
From
EUR$5,850USDGBP
From
EUR$6,499USDGBP
From
EUR$3,500USDGBP
Crohn's Disease (CD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Crohn's Disease (CD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Crohns Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Crohns Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 100 Pages
  • Global
From
EUR$3,000USDGBP
From
EUR$4,950USDGBP
From
EUR$4,500USDGBP
Crohn's Disease Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Crohn's Disease Epidemiology Analysis and Forecast to 2032

  • Report
  • August 2023
  • 47 Pages
  • Global
From
EUR$3,995USDGBP
Crohn's Disease - Epidemiology Forecast to 2029 - Product Thumbnail Image

Crohn's Disease - Epidemiology Forecast to 2029

  • Report
  • September 2020
  • 47 Pages
  • Global
From
EUR$3,995USDGBP
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 Pages
  • Global
From
EUR$2,000USDGBP
US Crohn's Disease Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Crohn's Disease Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
EUR$1,940USDGBP
From
EUR$1,090USDGBP
From
EUR$3,990USDGBP
Loading Indicator

Crohn Disease is a chronic inflammatory disorder of the gastrointestinal tract, and is one of the most common immune disorders. Treatment for Crohn Disease typically involves a combination of medications, lifestyle changes, and in some cases, surgery. Common medications used to treat Crohn Disease include corticosteroids, immunomodulators, biologic therapies, and antibiotics. Corticosteroids are used to reduce inflammation, while immunomodulators are used to suppress the immune system. Biologic therapies are used to target specific proteins in the body that are involved in the inflammatory process, and antibiotics are used to treat bacterial infections. The Crohn Disease Drug market is a rapidly growing segment of the Immune Disorders Drugs market. It is driven by the increasing prevalence of Crohn Disease, as well as the development of new and innovative treatments. Companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Pfizer, and UCB. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more